Suppr超能文献

肺血管疾病谱中的临床特征和无移植生存情况。

Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease.

机构信息

Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

J Am Coll Cardiol. 2022 Aug 16;80(7):697-718. doi: 10.1016/j.jacc.2022.05.038.

Abstract

BACKGROUND

PVDOMICS (Pulmonary Vascular Disease Phenomics) is a precision medicine initiative to characterize pulmonary vascular disease (PVD) using deep phenotyping. PVDOMICS tests the hypothesis that integration of clinical metrics with omic measures will enhance understanding of PVD and facilitate an updated PVD classification.

OBJECTIVES

The purpose of this study was to describe clinical characteristics and transplant-free survival in the PVDOMICS cohort.

METHODS

Subjects with World Symposium Pulmonary Hypertension (WSPH) group 1-5 PH, disease comparators with similar underlying diseases and mild or no PH and healthy control subjects enrolled in a cross-sectional study. PH groups, comparators were compared using standard statistical tests including log-rank tests for comparing time to transplant or death.

RESULTS

A total of 1,193 subjects were included. Multiple WSPH groups were identified in 38.9% of PH subjects. Nocturnal desaturation was more frequently observed in groups 1, 3, and 4 PH vs comparators. A total of 50.2% of group 1 PH subjects had ground glass opacities on chest computed tomography. Diffusing capacity for carbon monoxide was significantly lower in groups 1-3 PH than their respective comparators. Right atrial volume index was higher in WSPH groups 1-4 than comparators. A total of 110 participants had a mean pulmonary artery pressure of 21-24 mm Hg. Transplant-free survival was poorest in group 3 PH.

CONCLUSIONS

PVDOMICS enrolled subjects across the spectrum of PVD, including mild and mixed etiology PH. Novel findings include low diffusing capacity for carbon monoxide and enlarged right atrial volume index as shared features of groups 1-3 and 1-4 PH, respectively; unexpected, frequent presence of ground glass opacities on computed tomography; and sleep alterations in group 1 PH, and poorest survival in group 3 PH. PVDOMICS will facilitate a new understanding of PVD and refine the current PVD classification. (Pulmonary Vascular Disease Phenomics Program PVDOMICS [PVDOMICS]; NCT02980887).

摘要

背景

PVDOMICS(肺血管疾病表型组学)是一项精准医学计划,旨在通过深度表型分析来描述肺血管疾病(PVD)。PVDOMICS 检验了这样一种假设,即整合临床指标与组学测量结果将增强对 PVD 的理解,并促进更新的 PVD 分类。

目的

本研究旨在描述 PVDOMICS 队列的临床特征和无移植生存率。

方法

在这项横断面研究中,纳入了患有世界肺高压研讨会(WSPH)第 1-5 组肺动脉高压(PH)、具有相似基础疾病且 PH 程度较轻或无 PH 以及健康对照的受试者。使用标准统计检验(包括比较移植或死亡时间的对数秩检验)比较 PH 组、对照组。

结果

共纳入 1193 名受试者。38.9%的 PH 受试者被分为多个 WSPH 组。与对照组相比,1 组、3 组和 4 组 PH 受试者夜间更易出现低氧血症。1 组 PH 受试者中,50.2%的人胸部 CT 有磨玻璃影。1-3 组 PH 受试者的一氧化碳弥散量明显低于各自的对照组。与对照组相比,WSPH 第 1-4 组的右心房容积指数更高。共有 110 名参与者的平均肺动脉压为 21-24mmHg。3 组 PH 的无移植生存率最差。

结论

PVDOMICS 纳入了 PVD 谱中的受试者,包括轻度和混合病因 PH。新发现包括:1-3 组和 1-4 组 PH 分别有共同的特征,即一氧化碳弥散量低和右心房容积指数增大;CT 上意外且频繁出现磨玻璃影;1 组 PH 有睡眠改变;3 组 PH 的生存率最差。PVDOMICS 将促进对 PVD 的新认识,并完善目前的 PVD 分类。(肺血管疾病表型组学计划 PVDOMICS [PVDOMICS];NCT02980887)

相似文献

5
Pulmonary hypertension across the spectrum of left heart and lung disease.左心和肺部疾病相关肺动脉高压
Eur J Heart Fail. 2024 Jul;26(7):1642-1651. doi: 10.1002/ejhf.3302. Epub 2024 Jun 4.
7
Oral morphine for cancer pain.口服吗啡用于癌症疼痛。
Cochrane Database Syst Rev. 2016 Apr 22;4(4):CD003868. doi: 10.1002/14651858.CD003868.pub4.

引用本文的文献

3
A Peek into Pulmonary Hypertension through the Plasma Proteome.透过血浆蛋白质组窥探肺动脉高压
Am J Respir Crit Care Med. 2025 Aug;211(8):1339-1340. doi: 10.1164/rccm.202505-1063ED.

本文引用的文献

6
Diagnosis of pulmonary hypertension.肺动脉高压的诊断。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01904-2018. Print 2019 Jan.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验